Top 13 investors in Eastern Asia with the biggest sum of Private Equity funding rounds in Biotechnology industry over the recent years

Intro

The top 13 investors according to the total money raised in the funding rounds. These are VC funds and corporate investors in Eastern Asia that have invested in Private Equity stage over the last 5 years. They are actively investing in Biotechnology industry.
Biotechnology is the use of biology to make or develop products. It includes biopharmaceutical, genetics, and neuroscience.

Amount of money raised in Biotechnology funding rounds is $2.0B, which is 2.7% of the total amount of money raised in Private Equity rounds in Eastern Asia over the last 5 years.

Top 13 investors in Eastern Asia with the biggest sum of Private Equity funding rounds in Biotechnology industry over the recent years
data provided by Unicorn Nest

Key takeaways

• Funds Geography – All VCs are located in China. There is an equal amount of VCs in Hong Kong Island and Beijing which host 4 funds each. There are also funds from Shanghai and Xicheng. There are 2 countries that funds tend to invest in: China and The United States with the majority investing in China. For the majority of the funds, the country of the funds’ establishment and the country of their most frequent investments coincide.
• Industry Focus – The funds’ most common field for investments is Finance. They also invest in Bio & Nano Technology, Medical Service and E-Commerce Platforms.
• Important Years – The oldest fund in the sample was founded in 1984 and the newest one in 2015. In 2008 the most amount of funds were founded. 2018 holds the most deals for 6 VCs. 2021, 2017 and 2019 were also fruitful.
• Investments – Usually VCs take part in 2 funding rounds per year, sometimes in 2 – 6. The minimum number of funding rounds for VCs in the sample is 9, the maximum is 165. Average number of funding rounds is 49.7 while median is 33.0. The most common amount of funding rounds for VCs in the sample is 11. Minimum amount of lead investments for funds is 3 and maximum is 41. Average amount of lead investments is 11.5 while median is 7.0. The most common amount of lead investments is 3. Index of difference in percentage points of lead investments from the average is between -25.55 and 16.76 for funds in the sample. The average value for this difference is 1.49 and the median is 3.47. It means that these funds act as lead investors more often than other funds. The most common value is 1.73.
• Typical Rounds – Funds participate in rounds with 5 – 6 or 3 – 4 investors The most common round size for VCs in the sample is more than 1 billion. Less common range is 500 million – 1 billion. A Funds’ average multiplicator for portfolio companies at the last known valuation is close to zero at minimum and 8.99 at maximum. Average value for this multiplicator is 2.73 and median is 1.65.